ArticleAnnals of medicine and surgery (2012)2026
FDA approval of the Lumipulse G PTau217/β-amyloid 1-42 plasma ratio test: a new era in accessible Alzheimer's diagnosis.
Biruk D Ayalew et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.